Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection
In conclusion, PEG-IFNα, especially in combination with skin-directed therapies, is an effective treatment option for cutaneous T-cell lymphoma in clinical practice.PMID:37902466 | PMC:PMC10622159 | DOI:10.2340/actadv.v103.10306 (Source: Acta Dermato-Venereologica)
Source: Acta Dermato-Venereologica - October 30, 2023 Category: Dermatology Authors: Janika Gosmann Rudolf Stadler Koen D Quint Ralf Gutzmer Maarten H Vermeer Source Type: research
Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection
In conclusion, PEG-IFNα, especially in combination with skin-directed therapies, is an effective treatment option for cutaneous T-cell lymphoma in clinical practice.PMID:37902466 | PMC:PMC10622159 | DOI:10.2340/actadv.v103.10306 (Source: Acta Derm Venereol A...)
Source: Acta Derm Venereol A... - October 30, 2023 Category: Dermatology Authors: Janika Gosmann Rudolf Stadler Koen D Quint Ralf Gutzmer Maarten H Vermeer Source Type: research
Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection
In conclusion, PEG-IFNα, especially in combination with skin-directed therapies, is an effective treatment option for cutaneous T-cell lymphoma in clinical practice.PMID:37902466 | PMC:PMC10622159 | DOI:10.2340/actadv.v103.10306 (Source: Acta Dermato-Venereologica)
Source: Acta Dermato-Venereologica - October 30, 2023 Category: Dermatology Authors: Janika Gosmann Rudolf Stadler Koen D Quint Ralf Gutzmer Maarten H Vermeer Source Type: research
Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection
In conclusion, PEG-IFNα, especially in combination with skin-directed therapies, is an effective treatment option for cutaneous T-cell lymphoma in clinical practice.PMID:37902466 | PMC:PMC10622159 | DOI:10.2340/actadv.v103.10306 (Source: Acta Derm Venereol A...)
Source: Acta Derm Venereol A... - October 30, 2023 Category: Dermatology Authors: Janika Gosmann Rudolf Stadler Koen D Quint Ralf Gutzmer Maarten H Vermeer Source Type: research
Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection
In conclusion, PEG-IFNα, especially in combination with skin-directed therapies, is an effective treatment option for cutaneous T-cell lymphoma in clinical practice.PMID:37902466 | PMC:PMC10622159 | DOI:10.2340/actadv.v103.10306 (Source: Acta Dermato-Venereologica)
Source: Acta Dermato-Venereologica - October 30, 2023 Category: Dermatology Authors: Janika Gosmann Rudolf Stadler Koen D Quint Ralf Gutzmer Maarten H Vermeer Source Type: research
Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection
In conclusion, PEG-IFNα, especially in combination with skin-directed therapies, is an effective treatment option for cutaneous T-cell lymphoma in clinical practice.PMID:37902466 | PMC:PMC10622159 | DOI:10.2340/actadv.v103.10306 (Source: Acta Derm Venereol A...)
Source: Acta Derm Venereol A... - October 30, 2023 Category: Dermatology Authors: Janika Gosmann Rudolf Stadler Koen D Quint Ralf Gutzmer Maarten H Vermeer Source Type: research
In the skin lesions of patients with mycosis fungoides, the number of MRGPRX2-expressing cells is increased and correlates with mast cell numbers
ConclusionsOur findings point to the role of MRGPRX2 and MC in the pathogenesis of MF that should be investigated in further studies. (Source: Frontiers in Immunology)
Source: Frontiers in Immunology - October 30, 2023 Category: Allergy & Immunology Source Type: research
Dupilumab, Atopic Dermatitis, and Mycosis Fungoides
In this issue of JAMA Dermatology, Boesjes et al share their experience with patients with presumed atopic dermatitis (AD) who, shortly after dupilumab initiation, experienced worsening skin symptoms unlike their previous disease. Skin biopsies were characterized by atypical T-cell lymphocytic infiltrates. Although some of these patients developed mycosis fungoides (MF), most of their cases resolved spontaneously on discontinuation of dupilumab and were diagnosed with lymphoid reactions (LRs), a transitory drug-induced lymphomatoid reaction. This novel observation merits reflection, in view of several recent reports of cut...
Source: JAMA Dermatology - October 18, 2023 Category: Dermatology Source Type: research
Allogeneic stem cell transplant for treatment of mycosis fungoides and Sezary syndrome: a systematic review and meta-analysis
Bone Marrow Transplantation, Published online: 18 October 2023; doi:10.1038/s41409-023-02122-0Allogeneic stem cell transplant for treatment of mycosis fungoides and Sezary syndrome: a systematic review and meta-analysis (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - October 18, 2023 Category: Hematology Authors: Amrita Goyal Daniel O ’Leary Francine Foss Source Type: research
The Burden of Skin Cancers in Saudi Arabia Through 2011-2022
Conclusion The incidences of SCC and BCC are relatively high in comparison to other types of skin cancers with the surgical intervention being most frequently used.PMID:37829962 | PMC:PMC10566748 | DOI:10.7759/cureus.45052 (Source: Herpes)
Source: Herpes - October 13, 2023 Category: Infectious Diseases Authors: Mansour N AlOtaibi Abdullah S Basfar Amjad M Jawhari Essam S Alzahrani Mohammed A Althomali Adnan E Alhindi Samir S Alam Daifallah M Al Aboud Ahmed S Abdel-Moneim Source Type: research
Evaluating Response Trends of Chlormethine/Mechlorethamine Gel in Patients With Stage I-IIA Mycosis Fungoides: Analysis of Individual Patient Data From a Randomized Controlled Phase II Study to Facilitate Optimal Treatment Experiences
CONCLUSIONS: Results presented here can facilitate optimal treatment experiences for patients starting CL gel.PMID:37802679 | DOI:10.1016/j.clml.2023.08.020 (Source: Clinical Lymphoma and Myeloma)
Source: Clinical Lymphoma and Myeloma - October 6, 2023 Category: Cancer & Oncology Authors: Larisa J Geskin James T Angello Martine Bagot Emmanuella Guenova Neda Nikbakht Christiane Querfeld Julia J Scarisbrick Source Type: research
Evaluating Response Trends of Chlormethine/Mechlorethamine Gel in Patients With Stage I-IIA Mycosis Fungoides: Analysis of Individual Patient Data From a Randomized Controlled Phase II Study to Facilitate Optimal Treatment Experiences
CONCLUSIONS: Results presented here can facilitate optimal treatment experiences for patients starting CL gel.PMID:37802679 | DOI:10.1016/j.clml.2023.08.020 (Source: Clinical Lymphoma and Myeloma)
Source: Clinical Lymphoma and Myeloma - October 6, 2023 Category: Cancer & Oncology Authors: Larisa J Geskin James T Angello Martine Bagot Emmanuella Guenova Neda Nikbakht Christiane Querfeld Julia J Scarisbrick Source Type: research
Evaluating Response Trends of Chlormethine/Mechlorethamine Gel in Patients With Stage I-IIA Mycosis Fungoides: Analysis of Individual Patient Data From a Randomized Controlled Phase II Study to Facilitate Optimal Treatment Experiences
CONCLUSIONS: Results presented here can facilitate optimal treatment experiences for patients starting CL gel.PMID:37802679 | DOI:10.1016/j.clml.2023.08.020 (Source: Clinical Lymphoma and Myeloma)
Source: Clinical Lymphoma and Myeloma - October 6, 2023 Category: Cancer & Oncology Authors: Larisa J Geskin James T Angello Martine Bagot Emmanuella Guenova Neda Nikbakht Christiane Querfeld Julia J Scarisbrick Source Type: research
Evaluating Response Trends of Chlormethine/Mechlorethamine Gel in Patients With Stage I-IIA Mycosis Fungoides: Analysis of Individual Patient Data From a Randomized Controlled Phase II Study to Facilitate Optimal Treatment Experiences
CONCLUSIONS: Results presented here can facilitate optimal treatment experiences for patients starting CL gel.PMID:37802679 | DOI:10.1016/j.clml.2023.08.020 (Source: Clinical Lymphoma and Myeloma)
Source: Clinical Lymphoma and Myeloma - October 6, 2023 Category: Cancer & Oncology Authors: Larisa J Geskin James T Angello Martine Bagot Emmanuella Guenova Neda Nikbakht Christiane Querfeld Julia J Scarisbrick Source Type: research
Evaluating Response Trends of Chlormethine/Mechlorethamine Gel in Patients With Stage I-IIA Mycosis Fungoides: Analysis of Individual Patient Data From a Randomized Controlled Phase II Study to Facilitate Optimal Treatment Experiences
CONCLUSIONS: Results presented here can facilitate optimal treatment experiences for patients starting CL gel.PMID:37802679 | DOI:10.1016/j.clml.2023.08.020 (Source: Clinical Lymphoma and Myeloma)
Source: Clinical Lymphoma and Myeloma - October 6, 2023 Category: Cancer & Oncology Authors: Larisa J Geskin James T Angello Martine Bagot Emmanuella Guenova Neda Nikbakht Christiane Querfeld Julia J Scarisbrick Source Type: research
